IO Biotech, Inc. (IOBT) has 17 open-market insider trades by 13 insiders since 2021. The most active filer is Novo Holdings A/S, 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Invest A/s Lundbeckfond | 10% Owner | — | 1 | $30.0M | 2023-08-09 |
| Novo Holdings A/S | 10% Owner | — | 4 | $13.8M | 2024-07-26 |
| Vivo Capital IX, LLC | 10% Owner | — | 1 | $12.0M | 2023-08-09 |
| Jack Nielsen | Dir | — | 1 | $9.1M | 2021-11-09 |
| HBM Healthcare Investments (Cayman) Ltd. | 10% Owner | — | 1 | $4.5M | 2021-11-09 |
| Vanessa Malier | Dir | — | 1 | $2.3M | 2021-11-09 |
| Claus A. Andersson | Dir | — | 1 | $1.1M | 2021-11-09 |
| Amy Sullivan | CFO | — | 2 | $125K | 2024-12-23 |
| Qasim Iftikhar Ahmad | Chief Medical Officer | — | 1 | $27K | 2024-12-23 |
| Heidi Hunter | Dir | — | 1 | $21K | 2025-05-30 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Heidi Hunter | Director | Buy | $21K | 2025-05-30 |
| Devin Whittemore Smith | General Counsel | Buy | $10K | 2024-12-23 |
| Mai-Britt Zocca | CEO | Buy | $10K | 2024-12-23 |
| Qasim Iftikhar Ahmad | Chief Medical Officer | Buy | $27K | 2024-12-23 |
| Amy Sullivan | CFO | Buy | $9K | 2024-12-23 |
| Novo Holdings A/S | 10% Owner | Sell | $168K |
Companies that share insiders with IOBT, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2024-07-25 |
| Novo Holdings A/S | 10% Owner | Sell | $1.6M | 2024-05-10 |
| Novo Holdings A/S | 10% Owner | Sell | $2.0M | 2024-02-09 |
| Brian Burkavage | Chief Accounting Officer | Buy | $10K | 2023-11-21 |
| Vivo Capital IX, LLC | 10% Owner | Buy | $12.0M | 2023-08-09 |
| Novo Holdings A/S | 10% Owner | Buy | $10.0M | 2023-08-09 |
| Amy Sullivan | CFO | Buy | $116K | 2023-03-17 |
| Vanessa Malier | Director | Buy | $2.3M | 2021-11-09 |
| Jack Nielsen | Director | Buy | $9.1M | 2021-11-09 |
| HBM Healthcare Investments (Cayman) Ltd. | 10% Owner | Buy | $4.5M | 2021-11-09 |